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Adenomyosis is characterized by invasion of endometrial glands and stromal cells into the myometrium.
It is a common gynecological disorder that usually occurs in women during their reproductive years. The
primary clinical manifestations of adenomyosis are menorrhagia and progressive dysmenorrhea. The
pathogenesis of adenomyosis-associated dysmenorrhea is complicated. However, it is predicted that
oxytocin, inﬂammatory factors, and prostaglandin F2a are responsible for adenomyosis-associated
dysmenorrhea via the induction of uterine smooth muscle contractions. Additionally, the pain conduc-
tivity of the pelvic viscera (internal organs) involves both the sympathetic (T10eL1) and parasympathetic
(S2e4) nervous systems located in the abdominal region. This article provides a review of the patho-
physiology of dysmenorrhea in adenomyosis and the nociceptive afferent pathway of the pelvic
splanchnic nerves.
Copyright © 2016, The Asia-Paciﬁc Association for Gynecologic Endoscopy and Minimally Invasive
Therapy. Published by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Adenomyosis is characterized by the presence of heterotopic
endometrial glands and stroma within the myometrium, accom-
panied by a variable degree of adjacent myometrial hyperplasia and
inﬁltration of inﬂammatory cells.1,2 Menorrhagia and dysmenor-
rhea are the two major adenomyosis-associated symptoms, and >
30% of patients with these symptoms have typical secondary,
progressive dysmenorrhea.3 Dysmenorrhea is also the main reason
that women seek medical attention for uterine adenomyosis. The
pathogenesis of adenomyosis and adenomyosis-associated
dysmenorrhea is complicated. To provide an effective treatment,
it is important to understand and clarify the pathophysiology of
dysmenorrhea in adenomyosis and the nociceptive afferent
pathway of the pelvic splanchnic nerves.Types of dysmenorrhea in adenomyosis and
pathophysiological factors
According to different pathological changes, clinically, there are
two types of dysmenorrhea in adenomyosis, lateral and midline.4of interest relevant to this
niversity School of Medicine,
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nc-nd/4.0/).Lateral dysmenorrhea is related to the pathological changes of
the adjacent pelvic organs, such as inﬂammatory adhesion of the
accessory or peritoneum. This refers to the complicated nocicep-
tive afferent pathway of the pelvic organs and peritoneum, which
is reported as referred pain in most cases, with no signiﬁcant ef-
ﬁcacy for nonsteroidal anti-inﬂammatory drugs and presacral
neurectomy. Midline dysmenorrhea is a typical form of dysmen-
orrhea in adenomyosis and can be triggered either by nerve
secretory factors, which directly stimulate the spasmodic con-
tractions of the uterine smooth muscle, or by inﬂammatory cyto-
kines and chemical neurotransmitters, which indirectly stimulate
nerve endings. Nonsteroidal anti-inﬂammatory drugs and pre-
sacral neurectomy show some efﬁcacy towards this form of
dysmenorrhea.
Nerve secretory factors
Within the nerve secretory pathway, pituitrin and its de-
rivatives, such as vasopressin and oxytocin, stimulate vascular and
uterine smooth muscle cells to contract. Ischemic hypoxia and acid
products accumulate as pain factors outside cells to cause sodium
channel phosphorylation, enhance receptor excitation, activate
several silent nociceptors, or damage low threshold mechanore-
ceptors, resulting in the sensitization of primary afferent nerves.
This leads to the abnormal expression of ion channels in primary
afferent nerve ﬁbers, and peripheral sensitization causes hyper-
algesia and dysmenorrhea. Vasopressin and oxytocin are the most
important factors regulating uterine contractions. Vasopressin-1ay InvasiveTherapy. PublishedbyElsevierTaiwanLLC. This isanopenaccessarticleunder theCC
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adenomyosis, and the oxytocin receptor (OTR) in uterine smooth
muscle cells is positively correlated with the amplitude of uterine
contraction.5 Mechsner et al5 used an immunohistochemical ex-
amination for both OTR and VP1aR expression in the endometrium,
myometrium and adenomyotic lesions in 40 patients with histo-
logically proven adenomyosis and 40 patients without adeno-
myosis who underwent hysterectomy for dysmenorrhea, bleeding
disorders, and ﬁbroids. The results showed that VP1aR was only
expressed in myometrial cells and blood vessels, and no immuno-
reactive staining of VP1aR in the epithelial and stromal cells of an
adenomyotic lesion or endometrial cells was detected. The VP
pathway related to the development of dysmenorrhea may be
related to myometrial hyperactivity with reduced uterine blood
ﬂow due to increased VP plasma levels. It also shows that there are
no differences in the endometrial OTR expression pattern between
the uteri of patients with and without adenomyosis. In adenomy-
otic lesions, OTR expression was detectable in epithelial cells,
demonstrating moderate to strong cytosolic immunoreactive
staining. There is an overexpression of OTR in myometrial cells
surrounding the stromal cells during adenomyosis. However, these
myometrial cells are highly compact, and it is possible that OTR
overexpression is due to this compact morphology. Guo et al6 found
that the contractile amplitude and OTR expression levels were
signiﬁcantly higher in adenomyosis cases than controls. Dysmen-
orrhea visual analog scale scores correlated positively with the
contractile amplitude and OTR expression level. Both trichostatin A
(TSA) and andrographolide dose-dependently inhibit OTR expres-
sion in myometrial smooth muscle cells (MSMCs). In conclusion,
OTR overexpression in MSMCs may be responsible for increased
uterine contractility and adenomyosis-associated dysmenorrhea.
Zhang et al7 performed an experimental prospective clinical study
and provided information on the spatial and temporal character-
istics of OTR expression in the uterus in both normal women and
women with adenomyosis. Changes in OTR expression may lead to
abnormal uterine contractions and cause the reproductive failure
and dysmenorrhea associated with this condition.
Inﬂammatory factors
Proinﬂammatory/inﬂammatory cytokines acting as chemical
neurotransmitters can stimulate uterine contraction and cause
dysmenorrhea. Immune cells produce pain factors, such as tumor
necrosis factor and chemokine factors. Peripheral nerve sensitiza-
tion of the primary afferent nerve with L-glutamic acid, substance P,
and calcitonin gene-related peptide as its neurotransmitter cause
the abnormal expression of ion channels on primary afferent nerve
ﬁbers, thereby increasing the sensitivity of nociceptive sensory
neurons when stimulated. This eventually causes hyperalgesia and
dysmenorrhea. Nuclear factor (NF)-kB is a pivotal proinﬂammatory
transcription factor and can be activated by various proin-
ﬂammatory agents, growth factors, andoxidative stress; nearly all of
which are involved in adenomyosis and endometriosis. NF-kB pro-
teins themselves and the proteins regulated by NF-kB are linked to
proliferation, apoptosis, angiogenesis, and invasion. NF-kB in-
hibitors are promising for the treatment of endometriosis and ade-
nomyosis in animal models. Li et al8 designed a study with 29
patients (cases) with histologically conﬁrmed adenomyosis and 14
(controls) without adenomyosis or endometriosis to detect the
protein levels of the NF-kB subunits p50 and p65 in both cases and
controls. The constitutive NF-kB DNA-binding activity and protein
expression levels of p50 and p65 in cases were signiﬁcantly higher
than in the controls. The binding activity level correlated positively
with dysmenorrhea severity in cases, and compared to the control
endometrium, adenomyotic lesions had signiﬁcantly highercyclooxygenase (COX)-2, vascular endothelial growth factor, and
tissue factor (TF) protein (p<0.0017) andmRNA levels (p< 0.018), as
expected. We also found that the NF-kB binding activity correlated
positively with the severity of dysmenorrhea in adenomyosis.
Because of the feed-forward relationship between pro-inﬂamma-
tory factors, such as cytokines/chemokines, and NF-kB activation
and the cross-talk between chemokines and neuronal receptors, it is
likely that the activated NF-kB may result in the increased produc-
tion of proinﬂammatory chemokines, which subsequently activate
neuronal receptors and cause hyperalgesia and dysmenorrhea.
Prostaglandins
Prostaglandin (PG)2a can cause dysmenorrhea via direct or in-
direct pathways. The ectopic endometrium can produce PG2a,
similar to the normal endometrium. On the one hand, uterine hy-
perstimulation via PG2a irritation and blood vessel contracture can
cause uterine ischemia, as characterized by a lack of oxygen and
dysmenorrhea. On the other hand, COX in the inﬂammatory tissue is
activated, promoting an increase in the local PG2a and improving
the sensitivity of the nociceptors, leading to hyperalgesia. PG2a can
also cause dysmenorrhea by stimulating afferent nerve ﬁbers
directly. PG synthetase inhibitors inhibit local COX, blocking the
production of PGs and preventing uterine contractions and spasms,
to reduce or eliminate dysmenorrhea. Nie et al9 assessed the ectopic
and homologous eutopic endometrium from 50 women with ade-
nomyosis, and endometria from 18 women without adenomyosis
were used for immunohistochemical analysis of OTR and TRPV1
(transient receptor potential vanilloid type 1). Compared to the
normal endometrium, the immunoreactivity of OTR and TRPV1 was
signiﬁcantly increased in the ectopic endometrium. The immuno-
reactivity of OTR and TRPV1 was positively correlated with the
severity of dysmenorrhea and represented signiﬁcant predicators
for dysmenorrhea severity. TRPV1 is expressed by sensory neurons
and integrates multiple noxious stimuli on peripheral terminals or
primary sensory neurons, such as heat (> 43C), acid (pH < 5.9), and
inﬂammatory mediators. The authors proposed that because the
activation of TRPV1 in epidermal keratinocytes results directly in the
release of COX-2, increased TRPV1 expression in adenomyosis could
also induce the release of COX-2, contributing to dysmenorrhea and
its severity. In addition, both PGE2 and PGI2 can facilitate the acti-
vation of TRPV1, contributing to inﬂammatory pain and/or
dysmenorrhea in women with adenomyosis. As a molecular inte-
grator of noxious stimuli and inﬂammatory mediators, many of
these factors, such as PGs, are abundant in the adenomyosis foci in
the peripheral terminals of primary sensory neurons, and TRPV1
activation may trigger the release of neuropeptides, such as sub-
stance P and calcitonin gene-related peptide, causing increased
blood ﬂow and hyperalgesia and possibly dysmenorrhea.9
Other factors
The pathophysiological mechanism of dysmenorrhea in adeno-
myosis is complex. In addition to the above factors, there are other
factors related to dysmenorrhea. For example, there is increased
immunoreactivity to SLIT/roundabout (ROBO)1, and it is correlated
with the severityofdysmenorrhea in adenomyosis. SLIT is a secretory
glycoprotein consisting of three members, SLIT1e3. The receptor for
SLIT is the transmembrane protein ROBO,which currently consists of
four members, ROBO1e4. Compared to the normal endometrium,
SLIT expression is signiﬁcantly higher in the ectopic endometrium
fromwomenwith adenomyosis,while ROBO1 immunoreactivity and
microvessel density were signiﬁcantly higher in both eutopic and
ectopic endometria than the normal endometrium. SLIT/ROBO1-
mediated crosstalk in adenomyosis may facilitate angiogenesis,
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facilitating myometrial inﬁltration, and thus exacerbating dysmen-
orrhea.10 Liu et al11 used immunostaining andmicroscopicevaluation
to assess the presence and localization of TF in both eutopic and
ectopic endometria and normal endometrium. They found that the
TF staining levels in both eutopic and ectopic endometria were
signiﬁcantly correlated with the severity of dysmenorrhea (Spear-
man’s r¼ 0.51, p¼ 0.0001 and r¼ 0.31, p¼ 0.029, respectively). TF is a
cell-membrane-bound glycoprotein and a member of the cytokine
receptor superfamily. Conversely, thrombin, which is downstream to
TF in physiological conditions, can increase uterine contractility.
Therefore, a feed-forward loop could be established,with elevated TF
expression and increased contractility. The increased uterine
contractility may be easily perceived as pain or cramps due to in-
nervations and/or elevated TRPV1 signaling because women with
symptomatic adenomyosis are likely to experience central sensiti-
zation, similar to endometriosis.
Dysmenorrhea and pain nerve conduction
Pelvic splanchnic nerve anatomy
The pelvic viscera (internal organs) receive nerve impulses from
both sympathetic (thoracolumbar) and parasympathetic (cranio-
sacral) nervous systems. Visceral nociceptive ﬁbers mainly transmit
through the sympathetic nerve and parasympathetic nerve along
the side of the spinal cord side. The parasympathetic and sympa-
thetic pelvic nerves that dominate the pelvic organs (uterus,
rectum, and bladder) come from the second to fourth sacral seg-
ments (S2e4) and the 10th thoracic (T10) to the ﬁrst lumbar
segment (L1), respectively. T10 to L1 merge into the superior hy-
pogastric plexus (presacral nerve), situated in front of the sacrum
and lying within the boundaries of the interiliac triangle and the
dendritic or reticular triangle, also called the Cotte triangle.
The presacral nerves travel to the pelvis, together with the
second to fourth sacral segments (parasympathetic), eventually
merging into the inferior hypogastric plexus; also called the pelvic
splanchnic nerve, and this plexus divides into the vesical, middle
rectal and uterovaginal (Frankenhauser’s) plexuses at the para-
cervix. Uterovaginal plexuses lie on both sides of the cervix and
vagina as part of the uterosacral ligaments (USLs) that arrive in at
the paracervix. The vesical plexus lies on both sides of the bladder,
dominating the bladder detrusor and internal sphincter to control
urination. The rectal plexuses dominate the rectum and anal canal
and rectum anus sphincter, as well as the control of bowel move-
ments. In clinical practice, presacral nerve resection is a type of
treatment for dysmenorrheal in adenomyosis that blocks the pain
pathways of the uterus. However, the nerve branches of the bladder
or rectum can be damaged by surgery, leading to rectal and bladder
dysfunction, with complications, such as constipation and urinary
retention.12,13 A recent 2012 retrospective analysis over 6 years
demonstrated improvement in themidline pain in 73% (22 of 30) of
patients.14 To analyze the distribution of autonomic nerves in the
USL, Chen et al15 assessed their insertion into the uterine body and
cervix, and the USLs were cut into cervical, intermediate, and sacral
sections. They also marked the superﬁcial portion, the deep
portion, medial surface (the side of the USL close to the rectum),
and lateral surface (the side of the USL near the ureter) of the
samples at the same time. After hematoxylineeosin and immuno-
histochemistry staining, they found that the sympathetic nerves
are the major conduits of nerve ﬁbers in the USL. The content of the
sympathetic nerve is concentrated on the deep portion and the
distant section. Fujii et al16 found that the greatest number of nerve
ﬁber bundles was at a distance of 16.5e33 mm and a depth of
3e15 mm distal to the site of attachment of the USL to the uterinecervix. Furthermore, there were many more sympathetic and
parasympathetic nerve ﬁber bundles than sensory nerve ﬁber
bundles in the USL and its surrounding tissue.
Ramanah et al17 evaluated the precise anatomy of pelvic
splanchnic nerve and found that they represented the lateral
boundaries of the posterior cul-de-sac andwere positioned lateral to
the rectum and medial to the ureters. They attached distally to the
posterolateral aspect of the cervix at the level of the internal cervical
os and at the lateral vaginal fornix and proximally to the presacral
fascia and the S2eS4 vertebrae. The ligament had a fan shape, with
mean widths of 5.2± 0.9 cm, 2.7± 1.0 cm, and 2.0± 0.5 cm at the
sacral, intermediate and cervical portions, respectively. The USL is a
multifaceted, mesentery-like structure containing loose connective
tissue, smooth muscle, vessels, and autonomic nerve ﬁbers from the
inferior hypogastric plexus, with contributions from sacral nerves.
The USL hasmore nerve content than the cardinal ligament (CL). The
superﬁcial part consists mainly of smooth muscle peritoneal con-
nective tissue. The deep part consists primarily of nerve ﬁbers. The
pelvic plexus, splanchnic nerve plexus, bladder plexus, uterovaginal
plexuses, and connective tissue form a pelvic nerve plane behind the
uterinewall. The plane near the side of the uterus is the uterovaginal
plexuses, with the travel of the uterus deep vein dominating the feel
of the uterus. The pelvic splanchnic nerve and bladder branch of the
inferior hypogastric plexus form the T-shaped nerve plane.18 At
present, presacral neurectomy is used to treat the dysmenorrhea of
adenomyosis. The careful separation and block of the uterovaginal
plexuses is the key to reducing postoperative complications and
effectively relieving dysmenorrhea. The insufﬁcient resection depth
of the sacral ligament during the operation can increase the risk of
the postoperative recurrence of dysmenorrhea. A more recent ran-
domized controlled trial of 141 patients followed over 24 months
demonstrated improvement in dysmenorrhea, dyspareunia, and
quality of life in patients with endometriosis who underwent a
concurrent presacral neurectomy at the time of conservative lapa-
roscopic surgery over those who did not.14
Pain receptors and nerve terminals
Pain sensation begins with stimulation of a nociceptor, or nerve
ending, and the resultant activation of a sensory nerve. Nerve ﬁbers
are divided into A, B, and C categories, of which, A is divided into a,
b, g, and d subtypes. A signal passes through the lightly myelinated
A d ﬁbers, which are responsible for the response to cold and me-
chanical stimuli that produce stinging and sharp, fast pain. The C
ﬁbers are also stimulated and are associated with mechanical and
thermal stimuli to transmit warm pain. Specialized bodies are
responsible for the response to texture (Meissner’s corpuscles),
vibration, tickle, and deep pressure (pacinian corpuscles) and
proprioception (Rufﬁni’s corpuscles). The release of chemicals, such
as potassium, bradykinin, and arachidonic acid, from inﬂammatory
processes is an endogenous source of pain sensation.19 In inﬂam-
matory processes, the damaged cells release chemicals, including K,
bradykinin, and arachidonic acid; also called pain factors. When the
concentration of pain factors in the intercellular space exceeds a
certain threshold, nerve endings undergo a transmembrane inward
current, membrane depolarization, and action potential on the
nerve terminal of A d ﬁbers and C ﬁbers to the cerebral cortex
causing pain. The pelvic viscera receive nerve impulses from both
sympathetic and parasympathetic nervous systems. Adenomyosis
ectopic endometrium directly stimulates the peripheral nerve ﬁ-
bers of the myometrium and signals through the pelvic visceral
nerves and afferent spinal cord and brain to cause nerve pain. In
addition, in the early 21st century, to study the relationship be-
tween dysmenorrhea in endometriosis and nerve distribution,
histological sections of endometrial tissue were stained
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anti-protein gene product 9.5 and monoclonal mouse anti-
neuroﬁlament protein to identify nerve ﬁbers. The small nerve ﬁ-
bers were identiﬁed throughout the basal and functional layers of
the endometrium in all endometriosis patients, but were not seen
in the functional layer of the endometrium in any of the women
without endometriosis (p < 0.001). Additionally, the small nerve
ﬁbers detected in the functional layer in all women with endo-
metriosis may have important implications for understanding the
generation of pain in these patients.20,21 Zhang et al22 used a
retrospective immunohistochemical study with the same method
to assess 37womenwith uterine ﬁbroids and 29with adenomyosis,
and they reached the same conclusion. Adenomyosis and endo-
metriosis are caused by an ectopic endometrium with growth
functions. However, the mechanism by which these nerve ﬁbers
cause dysmenorrhea requires further study.
Conclusion
Adenomyosis is a common benign disorder that usually occurs
in women during their reproductive years, and dysmenorrhea is
one of the common clinical manifestations. It is also the main
reason that women seek medical attention for uterine adeno-
myosis. The pathogenesis of dysmenorrhea in adenomyosis is
complicated. The pathophysiology of dysmenorrhea in adeno-
myosis occurs via nerve secretory factors, inﬂammatory factors,
PGF2a, and other factors. The precise anatomy and nociceptive
afferent pathway of the pelvic splanchnic nerves should be studied
to clarify their roles, thereby providing more effective treatment
options for dysmenorrhea in adenomyosis.
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